• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Drug-Device Combinations

The top diabetes tech stories of 2025

December 30, 2025 By Sean Whooley

Medtronic Diabetes MiniMed 780G Instinct Sensor

As the year comes to a close, it’s time to look back at the numerous innovations across the diabetes technology industry in 2025. Once again, continuous glucose monitors (CGMs) and automated insulin delivery systems took most of the headlines, as the leaders in the space keep building on their platforms while challengers continue to enter […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: abbott, Beta Bionics, cequr, Dexcom, embecta, Glucotrack, Insulet, lifescan, Medtronic, modularmedical, PharmaSens, Senseonics, Sequel Med Tech, SiBionics, Tandem Diabetes Care, ViCentra

Clinical Ink, Tandem Diabetes Care partner on automated insulin delivery data

December 24, 2025 By Sean Whooley

Tandem Diabetes Care Clinical Ink

Clinical Ink announced that it entered into a collaboration with Tandem Diabetes Care (Nasdaq:TNDM) to integrate automated insulin delivery (AID) data. The collaboration enables the integration of Tandem’s t:slim X2 and Mobi AID systems with Clinical Ink’s GlucoseReady platform. This would provide an automated method for capturing AID system data in clinical trials. In the partnership, […]

Filed Under: Big Data, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Technology Tagged With: Clinical Ink, Tandem Diabetes Care

MannKind earns FDA nod for on-body infusor, new autoinjector patents

December 23, 2025 By Sean Whooley

MannKind Furoscix On-Body Infusor (1)

MannKind (Nasdaq:MNKD) announced today that the FDA approved its Furoscix (furosemide) on-body infusor for pediatric patients. The company also received additional IP protection for its investigational Furoscix ReadyFlow autoinjector. ReadyFlow remains under FDA review after the agency accepted a supplemental New Drug Application (sNDA) earlier this month. For the on-body infusor, the FDA approved the […]

Filed Under: Auto-injectors, Drug-Device Combinations, Food & Drug Administration (FDA), Pediatrics, Regulatory/Compliance, Technology Tagged With: mannkind

Diabeloop wins FDA nod for new automated insulin delivery algorithm

December 22, 2025 By Sean Whooley

Diabeloop DBLG2 algorithm FDA clearance

Diabeloop announced today that its DBLG2 algorithm for automated insulin delivery has received FDA 510(k) clearance. DBLG2 received authorization as a Class II interoperable automated glycemic controller (i-AGC). Clearance validates the algorithm’s interoperability and could bring more choice to people with diabetes, the company said on LinkedIn. It marks the latest milestone for the company’s […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Regulatory/Compliance, Technology Tagged With: Diabeloop, FDA

Medtronic Diabetes unit MiniMed files for IPO

December 19, 2025 By Sean Whooley

Medtronic Diabetes MiniMed Logo (1)

Medtronic (NYSE:MDT) announced today that its MiniMed Diabetes business filed with the SEC for a proposed initial public offering (IPO). The medtech giant said MiniMed filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC). It expects to complete the separation from Medtronic through a series of capital markets transactions. […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Initial Public Offering (IPO), Patient Monitoring, Technology, Wall Street Beat Tagged With: Medtronic, minimed

Tandem launches t:slim mobile app in Canada

December 18, 2025 By Sean Whooley

Tandem Diabetes Care Tandem Mobile app (1)

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it launched its t:slim mobile application for Android and iOS users in Canada. San Diego-based Tandem’s t:slim mobile app connects to the company’s t:slim X2 automated insulin delivery system. It enables users to deliver a bolus from their compatible smartphone. They can also wirelessly upload pump data to […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Technology Tagged With: Tandem Diabetes Care

GlucoModicum unveils Sofio needle-free CGM

December 18, 2025 By Sean Whooley

GlucoModicum Sofio needle-free glucose monitor (1)

GlucoModicum today unveiled Sofio, which it labels the world’s first needle-free glucose monitor based on magneto-hydrodynamics (MHD). MHD technology draws micro-samples of interstitial fluid through the skin. It measures glucose with established electrochemical sensor technology. The single-day sensor system delivers a periodic, personalized monitoring alternative to standard continuous glucose monitor (CGM) devices. Helsinki, Finland-based GlucoModicum’s […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: GlucoModicum

Medtronic rolls out MiniMed campaign for launch with Instinct sensor made by Abbott

December 17, 2025 By Sean Whooley

Medtronic Diabetes MiniMed 780G Instinct Sensor

Medtronic (NYSE:MDT) announced the launch of its “Own It” campaign for the rollout of its MiniMed 780G system and Instinct sensor made by Abbott. The campaign aims to bring awareness to the now available system that “works quietly in the background” while people with type 1 diabetes can go about their daily lives. Medtronic (soon […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Patient Monitoring, Technology Tagged With: abbott, Medtronic, minimed

Abbott launches Lingo OTC CGM in Walgreens

December 17, 2025 By Sean Whooley

Abbott Lingo over-the-counter CGM next to packaging

Abbott (NYSE:ABT) announced today that it made its Lingo over-the-counter continuous glucose monitor (CGM) available at Walgreens. People can purchase the Lingo biosensor both in Walgreens brick-and-mortar stores and online. This marks the latest expansion for Lingo as it penetrates different markets, starting with a launch through Amazon as its first retail agreement for the device earlier […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: abbott

Insulet expands Pod recycling program across U.S.

December 15, 2025 By Sean Whooley

Insulet (Nasdaq:PODD) announced today that it expanded its U.S. Pod recycling program, now making it available to all U.S. customers. The Pod recycling program, offered at no cost to customers, enables users to request a recycling kit online. This allows them to return their used Omnipods. Insulet then decontaminates the returned Pods before transporting them […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Technology Tagged With: Insulet

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 21
  • Page 22
  • Page 23
  • Page 24
  • Page 25
  • Interim pages omitted …
  • Page 374
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS